EC: 3.4.22.36
caspase-1 ()
Pathways
| pathway id | name |
|---|---|
| Reactome:R-HSA-9660826 | Purinergic signaling in leishmaniasis infection |
| Reactome:R-HSA-9679506 | SARS-CoV Infections |
| Reactome:R-MMU-5620971 | Pyroptosis |
| Reactome:R-HSA-5620971 | Pyroptosis |
| Reactome:R-HSA-9692914 | SARS-CoV-1-host interactions |
| Reactome:R-HSA-9664424 | Cell recruitment (pro-inflammatory response) |
| Reactome:R-HSA-9692916 | SARS-CoV-1 activates/modulates innate immune responses |
| Reactome:R-HSA-9658195 | Leishmania infection |
| Reactome:R-HSA-9678108 | SARS-CoV-1 Infection |
| Reactome:R-HSA-9824446 | Viral Infection Pathways |
| Reactome:R-RNO-5620971 | Pyroptosis |
| Reactome:R-HSA-9824443 | Parasitic Infection Pathways |
| Reactome:R-RNO-9953170 | GBP-mediated host defense |
| Reactome:R-DRE-9960519 | CASP4-mediated substrate cleavage |
| Reactome:R-DRE-9686114 | Activation of inflammatory caspases |
| Reactome:R-HSA-9953170 | GBP-mediated host defense |
| Reactome:R-RNO-9968551 | Regulation of GBP-mediated host defense |
| Reactome:R-DRE-9948001 | CASP4 inflammasome assembly |
| Reactome:R-HSA-9968551 | Regulation of GBP-mediated host defense |
| Reactome:R-HSA-1643685 | Disease |
| Reactome:R-HSA-74160 | Gene expression (Transcription) |
| Reactome:R-HSA-73857 | RNA Polymerase II Transcription |
| Reactome:R-HSA-844623 | The IPAF inflammasome |
| Reactome:R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes |
| Reactome:R-HSA-446652 | Interleukin-1 family signaling |
| Reactome:R-MMU-168256 | Immune System |
| Reactome:R-MMU-449147 | Signaling by Interleukins |
| Reactome:R-MMU-5357801 | Programmed Cell Death |
| Reactome:R-RNO-1169410 | Antiviral mechanism by IFN-stimulated genes |
| Reactome:R-RNO-446652 | Interleukin-1 family signaling |
| Reactome:R-DRE-168256 | Immune System |
| Reactome:R-HSA-5633008 | TP53 Regulates Transcription of Cell Death Genes |
| Reactome:R-HSA-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| Reactome:R-HSA-913531 | Interferon Signaling |
| Reactome:R-HSA-449147 | Signaling by Interleukins |
| Reactome:R-MMU-1280215 | Cytokine Signaling in Immune system |
| Reactome:R-RNO-5218859 | Regulated Necrosis |
| Reactome:R-RNO-168256 | Immune System |
| Reactome:R-RNO-913531 | Interferon Signaling |
| Reactome:R-RNO-449147 | Signaling by Interleukins |
| Reactome:R-HSA-5357801 | Programmed Cell Death |
| Reactome:R-HSA-212436 | Generic Transcription Pathway |
| Reactome:R-HSA-3700989 | Transcriptional Regulation by TP53 |
| Reactome:R-HSA-168256 | Immune System |
| Reactome:R-HSA-168249 | Innate Immune System |
| Reactome:R-HSA-622312 | Inflammasomes |
| Reactome:R-HSA-844615 | The AIM2 inflammasome |
| Reactome:R-HSA-448706 | Interleukin-1 processing |
| Reactome:R-MMU-446652 | Interleukin-1 family signaling |
| Reactome:R-RNO-5357801 | Programmed Cell Death |
| Reactome:R-RNO-448706 | Interleukin-1 processing |
| Reactome:R-DRE-168249 | Innate Immune System |
| Reactome:R-HSA-5218859 | Regulated Necrosis |
| Reactome:R-HSA-5663205 | Infectious disease |
| Reactome:R-HSA-6803207 | TP53 Regulates Transcription of Caspase Activators and Caspases |
| Reactome:R-HSA-844456 | The NLRP3 inflammasome |
| Reactome:R-HSA-1280215 | Cytokine Signaling in Immune system |
| Reactome:R-HSA-9008059 | Interleukin-37 signaling |
| Reactome:R-MMU-448706 | Interleukin-1 processing |
| Reactome:R-MMU-5218859 | Regulated Necrosis |
| Reactome:R-RNO-1280215 | Cytokine Signaling in Immune system |
| PathBank:SMP0120910 | D4-GDI Signaling Pathway |
| PathBank:SMP0120958 | D4-GDI Signaling Pathway |
| PathBank:SMP0066935 | D4-GDI Signaling Pathway |